West Pharmaceutical Services | WST - Loan Capital


West Pharmaceutical Services reported $202.9M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Cooper Companies USD 1.86B 17.7M Mar/2026
Dentsply International USD 2B 10M Jun/2026
Haemonetics USD 1.17B 50.36M Jun/2026
ICU Medical USD 1.21B 49.38M Jun/2026
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
J&J USD 37.34B 183M Jun/2026
Medtronic USD 26.12B 1.76B Mar/2026
Merit Medical Systems USD 736.26M 1.1M Jun/2026
Neogen USD 793.7M 400K Mar/2026
OraSure Technologies USD 100K 17K Dec/2025
Quidel USD 2.54B 2.54B Jun/2026
Repligen USD 551.05M 4.46M Jun/2026
Rockwell Medical USD 8.65M 89K Jun/2025
Solventum Corp USD 4.57B 2M Jun/2026
STAAR Surgical USD 42K 42K Dec/2023
Terumo JPY 209.52B 109.61B Jun/2026
Utah Medical Products USD 0 0 Mar/2022
West Pharmaceutical Services USD 202.9M 100K Jun/2026